NCT04405323View on ClinicalTrials.gov

Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

July 28, 2020

Study Completion Date

July 28, 2020

Conditions
Healthy
Interventions
DRUG

Lu AG06466

hard capsules, orally, single doses

DRUG

Itraconazole

200 and 300 mg, capsules, orally

Trial Locations (1)

33126

US1517, Miami

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04405323 - Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women | Biotech Hunter | Biotech Hunter